Disclaimer:  VFC has no affiliation with Cel-Sci Corp or with any third parties associated with the companies.  VFC has received no compensation for this blog post, although there may be an unrelated advertisement or two at various locations on this blog.  VFC does not offer advice or investment services and nothing you read here should be construed as such.  VFC is just a guy with an opinion and access to a computer and a keyboard; bringing discussion and ideas to the table.  #AhYeah.

Shares of Cel-Sci Corp (CVM) are hot and in the spotlight these days after the company announced last week that the last "event," or death, necessary to complete data analysis for its global Phase III trial testing Multikine in the treatment of head and neck cancer had occurred.  After nearly a decade of waiting through many peaks and valleys of trading for CVM, investors were elated that the trial results are finally on their way.  There is much speculation, however, as to just how long the wait for analysis will take.  

According to the press release, "The database is now being prepared for database lock. Once the database has been locked the final analysis of the trial results can be performed."  write up by Zachs a few days ago does a pretty good job of outlining which steps may take place between the last event and data release.  A few of those steps could take a little bit of time, especially in the middle of this Covid19 pandemic that we are experiencing.  Zachs also mentioned the possibility of the data being discussed at an upcoming conference later this year...

Click 'Read more' below to read more.  First, use the link below for discounts to great backpacks and travel supplies!

Use this link for some awesome travel backpacks and supplies!  Using the code READYPROAF15 will get you a 15% discount at checkout!  Ah yeah!

Read more

Disclaimer:  VFC has no affiliation with Titan Pharmaceuticals or with any third parties associated with the companies.  VFC has received no compensation for this blog post, although there may be an unrelated advertisement or two at various locations on this blog.  VFC does not offer advice or investment services and nothing you read here should be construed as such.  VFC is just a guy with an opinion and access to a computer and a keyboard; bringing discussion and ideas to the table.  #AhYeah.

Shares of Titan Pharmaceuticals (TTNP) jumped by over twenty percent on Tuesday with volume nearly four times the daily norm.  After hours action brought another three percent rise in the price, bringing the daily gain to about twenty five percent.  Not bad for this stock that has been heavily beaten down since reaching highs of over two dollars last year.  

discussed this stock a on a couple of occasions last month when it became apparent that it was a good company to keep an eye on leading into the upcoming earnings report and it looks like some past event and future catalysts have drawn additional eyes onto Titan - it has also attracted the eyes of the swing, momentum and day traders, which means there will be plenty of volatility along with any upwards trend that may materialize.

Titan is a very speculative small cap company - market cap is still under thirty million even after yesterday's spike - but has a solid foundation of an approved product which treats a huge need in today's global environment.  That product is Probuphine.  

Click 'Read more' below to jump to the full blog post! Buy a plane ticket first, tho.  This lockdown won't last forever.

Fly Now, Pay Later. Easy monthly payments over 3, 6, or 12 months.

 

 

Read more